These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8547130)

  • 1. High proportions of VLA-5- immature myeloma cells correlated well with poor response to treatment in multiple myeloma.
    Kawano MM; Mahmoud MS; Huang N; Lisukov IA; Mihara K; Tsujimoto T; Kuramoto A
    Br J Haematol; 1995 Dec; 91(4):860-4. PubMed ID: 8547130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of immature and mature myeloma cells in the bone marrow of human myelomas.
    Kawano MM; Huang N; Harada H; Harada Y; Sakai A; Tanaka H; Iwato K; Kuramoto A
    Blood; 1993 Jul; 82(2):564-70. PubMed ID: 8329711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myeloma precursor cells].
    Iwato K; Kawano MM
    Rinsho Ketsueki; 1993 Apr; 34(4):433-8. PubMed ID: 7685432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of early plasma cells in peripheral blood and their clinical significance.
    Harada Y; Kawano MM; Huang N; Mahmoud MS; Lisukov IA; Mihara K; Tsujimoto T; Kuramoto A
    Br J Haematol; 1996 Jan; 92(1):184-91. PubMed ID: 8562394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of beta 1 integrins (very late antigens-4 and -5) on myeloma cells and clinical correlates in patients with multiple myeloma.
    Nishinarita S; Shimada H; Ito T; Namiki H; Kawahira H; Sawada U; Horie T
    J Int Med Res; 1998; 26(1):37-42. PubMed ID: 9513075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a monoclonal antibody to plasma cells: a comparison with CD38 and PCA-1.
    Hata H; Matsuzaki H; Matsuno F; Sonoki T; Takemoto S; Kuribayashi N; Nagasaki A; Takatsuki K
    Clin Exp Immunol; 1994 May; 96(2):370-5. PubMed ID: 8187346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells.
    Leo R; Boeker M; Peest D; Hein R; Bartl R; Gessner JE; Selbach J; Wacker G; Deicher H
    Ann Hematol; 1992 Mar; 64(3):132-9. PubMed ID: 1373957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The maturation of myeloma cells correlates with sensitivity to chemotherapeutic agents.
    Kuroda Y; Sakai A; Okikawa Y; Munemasa S; Katayama Y; Hyodo H; Imagawa J; Takimoto Y; Okita H; Ohtaki M; Kimura A
    Int J Hematol; 2005 May; 81(4):335-41. PubMed ID: 15914366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional phenotype of the primitive plasma cell in patients with multiple myeloma correlates with the clinical state.
    Pope B; Brown RD; Gibson J; Petersen A; Wiley J; Joshua DE
    Leuk Lymphoma; 1997 Sep; 27(1-2):83-91. PubMed ID: 9373199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An increase in MPC-1- and MPC-1-CD45+ immature myeloma cells in the progressive states of bone marrow plasmacytosis: the revised phenotypic classification of monoclonal marrow plasmacytosis (MOMP-2005).
    Otsuyama K; Asaoku H; Kawano MM
    Int J Hematol; 2006 Jan; 83(1):39-43. PubMed ID: 16443550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leu-19 in myeloma--a new role for an old antibody.
    Wetter O; Brandhorst D; Reiter W
    Eur J Cancer; 1990 Apr; 26(4):541. PubMed ID: 1694090
    [No Abstract]   [Full Text] [Related]  

  • 12. Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen.
    Schneider U; van Lessen A; Huhn D; Serke S
    Br J Haematol; 1997 Apr; 97(1):56-64. PubMed ID: 9136942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma: relationship between light chain isotype suppression, labelling index of plasma cells, and CD38 expression on peripheral blood lymphocytes.
    Joshua DE; Ioannidis R; Brown R; Francis SE; Gibson J; Kronenberg H
    Am J Hematol; 1988 Sep; 29(1):5-11. PubMed ID: 3052044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new staging system for multiple myeloma based on the number of S-phase plasma cells.
    San Miguel JF; García-Sanz R; González M; Moro MJ; Hernández JM; Ortega F; Borrego D; Carnero M; Casanova F; Jiménez R
    Blood; 1995 Jan; 85(2):448-55. PubMed ID: 7811998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis.
    Joshua D; Petersen A; Brown R; Pope B; Snowdon L; Gibson J
    Br J Haematol; 1996 Jul; 94(1):76-81. PubMed ID: 8757512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
    Kimlinger T; Witzig TE
    Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma: expression of nucleoside transporters on malignant plasma cells and their relationship to cellular proliferation.
    Petersen AJ; Brown RD; Pope BB; Jamieson GP; Paterson AR; Gibson J; Wiley JS; Joshua DE
    Leuk Lymphoma; 1994 May; 13(5-6):491-9. PubMed ID: 8069194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between S-phase fraction of myeloma cells and anemia in patients with multiple myeloma.
    Fosså A; Brandhorst D; Myklebust JH; Seeber S; Nowrousian MR
    Exp Hematol; 1999 Nov; 27(11):1621-6. PubMed ID: 10560909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of myeloma cells in peripheral blood using multi-parameter flow cytometry: monitoring residual disease].
    Klabusay M; Doubek M; Adam Z; Hájek R; Krivanová A
    Cas Lek Cesk; 2000 Jul; 139(14):432-6. PubMed ID: 11048405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phenotypic analysis of myeloma cells].
    Mihara K; Harada H; Kawano MM
    Nihon Rinsho; 1995 Mar; 53(3):574-9. PubMed ID: 7699888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.